SUNITINIB ZENTIVA
Capsule, hard, 25mg
RxActive license
Active substance (INN)
sunitinib
Pharmaceutical form
Pharmaceutical formCapsule, hard
Strength25mg
PackagingUkupno 30 kapsula tvrdih u bočici plastičnoj u kartonskoj kutiji
ManufacturerRemedica Ltd., Cyprus
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holderZENTIVA PHARMA DOO - DIO STRANOG DRUŠTVA PODGORICA
Authorization dateJuly 17, 2023
Analogs in Montenegro
20Other medicines with the same active substance
FASINDORRestricted
Capsule, hard, 50mgFASINDORRx
Capsule, hard, 12.5mgFASINDORRx
Capsule, hard, 25mgMISVENOLRx
Capsule, hard, 25mgMISVENOLRx
Capsule, hard, 50mgMISVENOLRx
Capsule, hard, 12.5mgSUNITINIB PLIVARestricted
Capsule, hard, 50 mgSUNITINIB PLIVARestricted
Capsule, hard, 25 mgSUNITINIB PLIVARestricted
Capsule, hard, 12.5 mgSUNITINIB SANDOZRx
Capsule, hard, 25mgSUNITINIB SANDOZRx
Capsule, hard, 50mgSUNITINIB SANDOZRx
Capsule, hard, 12.5mgSUNITINIB ZENTIVARx
Capsule, hard, 50mgSUNITINIB ZENTIVARx
Capsule, hard, 12.5mgSUNITINIB ZENTIVARx
Capsule, hard, 25mgSUNITINIB ZENTIVARx
Capsule, hard, 50mgSUNITINIB ZENTIVARx
Capsule, hard, 12.5mgSUTENTRx
Capsule, hard, 25mgSUTENTRx
Capsule, hard, 50mgSUTENTRx
Capsule, hard, 12.5mgSource: CInMED register